Unilever Oral Presentations
- Next Generation Risk Assessment for consumer safety: What do we need from validation? - Dr Carl Westmoreland
- Decision making in non-animal cosmetic safety assessment – Dr Paul Russell
- An industry perspective on strategies for integrating new approach methodologies for Next Generation Risk Assessment: coumarin as a case study – Dr Maria Baltazar
- In silico approaches to link adverse outcomes to molecular initiating events through AOPs – Dr Tim Allen
- AFSA module on Integrating in vitro data to establish a Margin of Exposure - Sophie Cable
- Integration of ReproTracker® into a next generation risk assessment (NGRA) approach - Dr Iris Muller
- Scientific workshop on Non-animal approaches for Chemical Safety in China: Current Progress and Outlook - Dr Carl Westmoreland
- Evaluation of a new approach methodology toolbox for the next generation risk assessment of systemic toxicity - Sophie Cable
Unilever Sponsored Sessions
- Accelerating use of new science and technology for Chemical Safety Assessment – chaired by Dr Gavin Maxwell
- Accelerating use of Computational Science for Chemical Safety Assessment – chaired by Dr Catherine Willett
- Industry and Federal Agencies working together for a common (non-animal) good: The Unilever and EPA Collaborative Research and Development Agreements (CRADA) – chaired by Dr Russell Thomas & Prof. Paul Carmichael
- Assessing non-specific cellular stress responses for Chemical Safety Assessment – chaired by Dr Paul Walker & Dr Paul Russell
- Cross Species Extrapolation: Opportunities for Chemical Safety Assessment – chaired by Dr Carl Westmoreland
- A collaborative approach to develop new NAMs for Chemical Safety Assessment – chaired by Dr Iris Muller
- Optimising in vitro methods through removal of serum components – chaired by Dr Carol Treasure & Dr Sarah Hatherell
Unilever Poster Presentations
- P22: Workshop on the Implementation of Next Generation Risk Assessment (NGRA) for Systemic Toxicity – Mabel Cotter
- P61: Next generation risk assessment of human exposure to anti-androgens using newly defined comparator compound values – Tessa van Tongeren
- P99: Next Generation Risk Assessment approach for Inhalation: Polymer case studies – Dr Maria Baltazar
- P100: Identifying and Characterising Stress Pathways of Concern for Consumer Safety in Next Generation Risk Assessments – Dr Maria Baltazar
- P106: A Next Generation Risk Assessment Case Study for Coumarin in Hypothetical Cosmetic Products – Sophie Cable
- P148: Practical application of in silico approaches in Next Generation Risk Assessment for consumer products – Dr Steve Gutsell
- P149: Framework for Physiologically-Based Kinetics (PBK) modelling in the Next Generation Risk Assessment (NGRA) of Consumer Goods – Dr Tom Moxon
- P151: Next Generation Risk Assessment (NGRA) for Skin Allergy: Use of Coumarin in Cosmetic Products, Ab Initio Case Study – Georgia Reynolds
- P262: Towards the Development of Animal Product-Free in vitro Systems for NGRA of Consumer Goods (PDF 265.6 KB) – Dr Sarah Hatherell
- P438: Non-Animal Safety Assessment Case Study of Phenoxyethanol in Cosmetics – Dr Matthew Dent (presented on behalf of Cosmetics Europe LRSS)
- P486: Building confidence in using new approach methodologies for consumer-based risk assessment: challenges and future perspectives – Dr Alistair Middleton
- P579: An in vitro panel for cosmetic chemical systemic toxicity safety testing – Dr Predrag Kukic (presented on behalf of Cosmetics Europe LRSS)